Clinical Trial Update: SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for SarCNU in recurrent or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SarCNU (sarCNU)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED